Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,276
archived clinical trials in
Pancreatic Cancer

A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Charlotte, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - Southpark
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Charlotte, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - Mallard Creek
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Charlotte, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - University
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Charlotte, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - Ballantyne
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Concord, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - Concord
mi
from
Concord, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Monroe, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute-Monroe
mi
from
Monroe, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Shelby, NC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Levine Cancer Institute - Cleveland
mi
from
Shelby, NC
Click here to add this to my saved trials
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  3/19/2018
mi
from
Charleston, SC
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
A Pilot Study Testing Single-Agent Regorafenib in Advanced Previously-Treated Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 3/19/2018
Low Country Hematology Oncology
mi
from
Charleston, SC
Click here to add this to my saved trials
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Status: Enrolling
Updated:  3/19/2018
mi
from
Rochester, MN
Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Phase I/IIA: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer
Status: Enrolling
Updated: 3/19/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/5/2018
mi
from
Los Angeles, CA
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/5/2018
mi
from
Aurora, CO
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
University of Colorado Hospital, Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/5/2018
mi
from
Indianapolis, IN
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/5/2018
mi
from
Philadelphia, PA
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated:  4/5/2018
mi
from
Nashville, TN
Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Status: Enrolling
Updated: 4/5/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Molecularly Tailored Therapy for Pancreas Cancer
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  4/6/2018
mi
from
Washington,
Molecularly Tailored Therapy for Pancreas Cancer
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
Georgetown University- Lombardi Comprehensive Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Molecularly Tailored Therapy for Pancreas Cancer
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  4/6/2018
mi
from
Olney, MD
Molecularly Tailored Therapy for Pancreas Cancer
A Pilot Study of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 4/6/2018
MedStar Montgomery Medical Center
mi
from
Olney, MD
Click here to add this to my saved trials
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  4/11/2018
mi
from
Little Rock, AR
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 4/11/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
mi
from
Scottsdale, AZ
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
mi
from
Kurralta Park,
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Ashford Cancer Centre
mi
from
Kurralta Park,
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
mi
from
Scottsdale, AZ
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Omaha, NE
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Indianapolis, IN
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Seattle, WA
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Milwaukee, WI
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Brussels,
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
CUB Hopital Erasme
mi
from
Brussels,
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
mi
from
Pittsburgh, PA
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials